Olson MT et al. |
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. |
2012 |
J. Thromb. Haemost. |
pmid:23072449
|
Cesari M et al. |
Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. |
2012 |
J. Gerontol. A Biol. Sci. Med. Sci. |
pmid:22389462
|
Wang Z et al. |
Aspirin resistance in off-pump coronary artery bypass grafting. |
2012 |
Eur J Cardiothorac Surg |
pmid:21636287
|
Li C et al. |
Reversal of the anti-platelet effects of aspirin and clopidogrel. |
2012 |
J. Thromb. Haemost. |
pmid:22268852
|
Mullins KB et al. |
Effects of carprofen, meloxicam and deracoxib on platelet function in dogs. |
2012 |
Vet Anaesth Analg |
pmid:22248445
|
Hartanto MD et al. |
Urinary 11-dehydro-thromboxane Bâ‚‚ and 2,3-dinor-6-keto-prostaglandin-Fâ‚α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg. |
2012 |
J. Thromb. Thrombolysis |
pmid:22311294
|
Lemkes BA et al. |
The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. |
2012 |
J. Thromb. Haemost. |
pmid:22252020
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
Sadilkova L et al. |
The effect of selected pre-analytical phase variables on plasma thromboxane Aâ‚‚ measurements in humans. |
2013 |
Int J Lab Hematol |
pmid:22908995
|